急性および慢性移植対宿主疾患の病理生理学における最近の進歩
Shuichiro Takahashi1, Daigo Hashimoto2
1Division of Hematology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
International journal of hematology
|February 13, 2026
まとめ
移植対宿主疾患 (GVHD) は,全種性幹細胞移植を複雑にします. T細胞枯渇と幹細胞再生を理解することは,GVHDを管理し,移植の成功を改善するための新しい戦略を提供します.
科学分野:
- 免疫学 免疫学とは
- 移植生物学 移植生物学について
- 幹細胞の研究について
背景:
- 移植対宿主疾患 (GVHD) は,アロゲン血球形成細胞移植 (allo-HCT) の成功に重大な障壁となっている.
- 組織幹細胞の再生と免疫細胞のダイナミクスは,GVHDの病原性と解消において極めて重要です.
研究 の 目的:
- 急性および慢性GVHDの背後にあるメカニズムを解明する.
- GVHDにおける組織幹細胞とT細胞枯渇の役割を調査する.
- GVHD管理のための新しい治療目標の特定.
主な方法:
- 実験モデルと臨床研究の分析.
- GVHD.HDを駆動する細胞および分子機構の調査.
- GVHD後の組織幹細胞における表遺伝的変化の評価.
主要な成果:
- 組織幹細胞の再生は,GVHDの耐性を高めます.
- 幹細胞の表遺伝的変異は,GVHDを悪化させる可能性があります.
- 慢性GVHDは,T細胞枯渇のダイナミクスを含む,複雑な免疫機能不調を伴う.
- 早期カルシネウリン阻害剤 (CNI) の使用は,T細胞の疲労を悪化させ,慢性GVHDを促進する可能性があります.
結論:
- 組織幹細胞機能を標的とし,T細胞枯渇を調節することは,GVHDの有望な治療法である.
- PTCyベースのプラットフォームにおける遅延CNI開始などの免疫抑制戦略の最適化は,有益なT細胞の枯渇を促進することにより,慢性GVHDを軽減することができます.
関連する概念動画
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
01:29Acute Kidney Injury II: Pathophysiology
1.2K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.2K
01:28Peptic Ulcer Disease II: Pathophysiology
2.2K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
01:26Coronary Artery Disease II: Pathophysiology
540
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
448
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
448
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
1.7K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.7K